A recent study conducted by the Aarhus University Hospital in Denmark found that three out of every four persons living with obesity and type 2 diabetes who receive a RYGB ( Roux-en-Y Gastric Bypass) experience remission within one year. Remission is defined as blood glucose levels at non-diabetes range without using diabetes medications.
This study followed 1,111 individuals who had an elevated BMI and type 2
The results of this study for people with type 2 and a BMI of 35 or greater who had RYGB:
In addition, those who had RYGB surgery had a significantly reduced risk of microvascular and possibly macrovascular complications compared to those who did not have surgery.
According to the authors of the study, RYGB is associated with a high remission rate and a decreased rate of vascular complications, especially if surgery in performed early after diabetes diagnosis.
For more information on this topic, read the full study in Diabetologia- Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study.
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!